Loading...
By Amy Orciari Herman
Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH
A new study adds to the evidence against routine blood glucose self-monitoring in patients with non-insulin-treated type 2 diabetes. The findings were published in JAMA Internal Medicine and presented at the American Diabetes Association's annual meeting.
Some 450 adults with non-insulin-dependent diabetes and hemoglobin A1c levels between 6.5% and 9.5% were randomized to one of three groups: no glucose self-monitoring; standard once-daily monitoring; or "enhanced" once-daily monitoring in which patients received tailored messages aimed at education and motivation.
At 1 year, the two primary outcomes — HbA1c improvements and health-related quality of life — did not differ across the groups. "This null result," the researchers note, "occurred despite training participants and primary care clinicians on the use and interpretation of the meter results."
They add that "more active engagement of both patients and clinicians may have improved patient outcomes, although this would have diminished the pragmatic nature of this study." They conclude that the results "suggest that glucose monitoring in patients with non-insulin-treated [type 2 diabetes] should not be routine."
Comment
LINK(S):
JAMA Internal Medicine article (Free)
JAMA Internal Medicine editor's note (Free)
Background: NEJM Journal Watch General Medicine coverage of meta-analysis on glucose self-monitoring in non-insulin-treated diabetes (Your NEJM Journal Watch registration required)